Osteoporotic bone formation in mice lacking tob2; involvement of Tob2 in RANK ligand expression and osteoclasts differentiation

[1]  A. Meng,et al.  Tob genes in development and homeostasis , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[2]  T. Noda,et al.  Oligo-astheno-teratozoospermia in mice lacking Cnot7, a regulator of retinoid X receptor beta , 2004, Nature Genetics.

[3]  K. Miyazono,et al.  Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Ohki,et al.  Altered Gene Expression in the Adult Brain of fyn-Deficient Mice , 2004, Cellular and Molecular Neurobiology.

[5]  M. Collart.  Global control of gene expression in yeast by the Ccr4-Not complex. , 2003, Gene.

[6]  Y. Toyoshima,et al.  Cdc2‐mediated phosphorylation of Kid controls its distribution to spindle and chromosomes , 2003, The EMBO journal.

[7]  H. Yasuda,et al.  Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis , 2002, Journal of Bone and Mineral Metabolism.

[8]  R. Kitazawa,et al.  Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter. , 2002, Biochemical and biophysical research communications.

[9]  Naoto Hirano,et al.  Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells , 2001, Nature Immunology.

[10]  T. Voeltzel,et al.  Relationships of the Antiproliferative Proteins BTG1 and BTG2 with CAF1, the Human Homolog of a Component of the Yeast CCR4 Transcriptional Complex , 2001, The Journal of Biological Chemistry.

[11]  Sakae Tanaka,et al.  Negative Regulation of BMP/Smad Signaling by Tob in Osteoblasts , 2000, Cell.

[12]  Miho Ohsugi,et al.  Cloning and Characterization of the Mouse tob2 Gene , 2000 .

[13]  D L Lacey,et al.  RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Voeltzel,et al.  The Leukemia-associated Protein Btg1 and the p53-regulated Protein Btg2 Interact with the Homeoprotein Hoxb9 and Enhance Its Transcriptional Activation* , 2000, The Journal of Biological Chemistry.

[15]  M. Hirai,et al.  Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases , 1999, Oncogene.

[16]  D. Lacey,et al.  The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature Osteoclasts , 1999, The Journal of cell biology.

[17]  S. Morony,et al.  OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis , 1999, Nature.

[18]  D. Lacey,et al.  Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.

[19]  L. M. Hanks.  Global control , 1997, Nature.

[20]  Conny Th. M. van Oostrom,et al.  Cloning and characterization of the mouse XPAC gene , 1994, Nucleic Acids Res..

[21]  Rudolf Jaenisch,et al.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.

[22]  T. Martin,et al.  Modulation of osteoclast differentiation. , 1992, Endocrine reviews.